New therapeutic target for Parkinson's disease discovered

JULY 19, 2023byNorthwestern UniversityImmunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. C

Updated on: March 15,2024

New therapeutic target for Parkinson's disease discovered

JULY 19, 2023byNorthwestern UniversityImmunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. C

Updated on:March 15,2024

Deep meditation may alter gut microbes for better health

by British Medical JournalCredit: Unsplash/CC0 Public DomainRegular deep meditation, practiced for several years, may help to regulate the gut microbiome and potentially lower the risks of physic

Updated on: May 23,2024

Deep meditation may alter gut microbes for better health

by British Medical JournalCredit: Unsplash/CC0 Public DomainRegular deep meditation, practiced for several years, may help to regulate the gut microbiome and potentially lower the risks of physic

Updated on:May 23,2024

Alzheimer's experts offer tips for 'dementia-friendly' homes

by Cara MurezWhile most homes aren't designed to be dementia-friendly, they can easily be adapted, according to a national Alzheimer's disease group."Virtually every aspect of a home can

Updated on: April 18,2024

Alzheimer's experts offer tips for 'dementia-friendly' homes

by Cara MurezWhile most homes aren't designed to be dementia-friendly, they can easily be adapted, according to a national Alzheimer's disease group."Virtually every aspect of a home can

Updated on:April 18,2024

Machine Learning for Alzheimer’s Disease: Unlocking the Future of Early Detection and Precision Care

Updated on: May 28,2025

Machine Learning for Alzheimer’s Disease: Unlocking the Future of Early Detection and Precision Care

Updated on:May 28,2025

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.This is a "remarkable milestone,

Updated on: April 02,2024

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.This is a "remarkable milestone,

Updated on:April 02,2024

Potential treatment for rare autoimmune disorder could be adapted from CAR-T therapy, suggests clinical trial

by National Institutes of HealthColorized scanning electron micrograph of a T lymphocyte (also known as a T cell) (blue). Credit: NIAIDEvidence from a small-scale clinical trial suggests that a v

Updated on: May 08,2024

Potential treatment for rare autoimmune disorder could be adapted from CAR-T therapy, suggests clinical trial

by National Institutes of HealthColorized scanning electron micrograph of a T lymphocyte (also known as a T cell) (blue). Credit: NIAIDEvidence from a small-scale clinical trial suggests that a v

Updated on:May 08,2024

Why poor sleep quality can be a matter of life and death for migrant roofers

by Amy McCaig,Rice UniversityCredit: Pixabay/CC0 Public DomainMigrant roofers in the U.S. helping communities rebuild from natural disasters often struggle with poor quality of sleep, according

Updated on: March 21,2024

Why poor sleep quality can be a matter of life and death for migrant roofers

by Amy McCaig,Rice UniversityCredit: Pixabay/CC0 Public DomainMigrant roofers in the U.S. helping communities rebuild from natural disasters often struggle with poor quality of sleep, according

Updated on:March 21,2024

Newly discovered genetic variant that causes Parkinson's disease clarifies why the condition develops and how to halt it

by Matthew Farrer,The ConversationSchematic outline of the methodological framework used in the study. Credit:The Lancet Neurology(2024). DOI: 10.1016/S1474-4422(24)00121-2Parkinson&

Updated on: April 27,2024

Newly discovered genetic variant that causes Parkinson's disease clarifies why the condition develops and how to halt it

by Matthew Farrer,The ConversationSchematic outline of the methodological framework used in the study. Credit:The Lancet Neurology(2024). DOI: 10.1016/S1474-4422(24)00121-2Parkinson&

Updated on:April 27,2024

The therapeutic window for Angelman syndrome patients may be broader than previously reported

by Texas Children's HospitalUbe3amRNA is diminished in the brain of a new maternalUbe3aknockout mouse but remains in a previously generated Angelman syndrome mouse model. (A) Sch

Updated on: January 21,2024

The therapeutic window for Angelman syndrome patients may be broader than previously reported

by Texas Children's HospitalUbe3amRNA is diminished in the brain of a new maternalUbe3aknockout mouse but remains in a previously generated Angelman syndrome mouse model. (A) Sch

Updated on:January 21,2024

New protein linked to early-onset dementia identified

by UK Research and InnovationCredit: UK Research and InnovationMost neurodegenerative diseases, including dementias, involve proteins aggregating into filaments called amyloids. In most of these

Updated on: February 24,2024

New protein linked to early-onset dementia identified

by UK Research and InnovationCredit: UK Research and InnovationMost neurodegenerative diseases, including dementias, involve proteins aggregating into filaments called amyloids. In most of these

Updated on:February 24,2024

Nutrition program for people with multiple sclerosis shows promising results

byCurtin UniversityCredit: Pixabay/CC0 Public DomainCurtin University researchers have trialed an online nutrition education program designed to help people with multiple sclerosis (MS) manage t

Updated on: October 04,2024

Nutrition program for people with multiple sclerosis shows promising results

byCurtin UniversityCredit: Pixabay/CC0 Public DomainCurtin University researchers have trialed an online nutrition education program designed to help people with multiple sclerosis (MS) manage t

Updated on:October 04,2024

New target for drug intervention in Alzheimer's disease identified

by University of Alabama at BirminghamInhibiting an enzyme called LIMK1 seems to improve the length and density of dendritic spines, shown here in green. Healthy dendritic spines are thought to h

Updated on: May 28,2024

New target for drug intervention in Alzheimer's disease identified

by University of Alabama at BirminghamInhibiting an enzyme called LIMK1 seems to improve the length and density of dendritic spines, shown here in green. Healthy dendritic spines are thought to h

Updated on:May 28,2024